SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013652
Filing Date
2023-08-08
Accepted
2023-08-07 17:35:46
Documents
93
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akya-20230630x10q.htm   iXBRL 10-Q 2280017
2 EX-31.1 akya-20230630xex31d1.htm EX-31.1 14847
3 EX-31.2 akya-20230630xex31d2.htm EX-31.2 14886
4 EX-32.1 akya-20230630xex32d1.htm EX-32.1 6808
5 EX-32.2 akya-20230630xex32d2.htm EX-32.2 7812
  Complete submission text file 0001558370-23-013652.txt   9782370

Data Files

Seq Description Document Type Size
6 EX-101.SCH akya-20230630.xsd EX-101.SCH 61216
7 EX-101.CAL akya-20230630_cal.xml EX-101.CAL 72672
8 EX-101.DEF akya-20230630_def.xml EX-101.DEF 237875
9 EX-101.LAB akya-20230630_lab.xml EX-101.LAB 538090
10 EX-101.PRE akya-20230630_pre.xml EX-101.PRE 418612
87 EXTRACTED XBRL INSTANCE DOCUMENT akya-20230630x10q_htm.xml XML 1951530
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40344 | Film No.: 231148686
SIC: 3826 Laboratory Analytical Instruments